IDE Cancer Research Results
IDE, Insulin-Degrading Enzyme: Click to Expand ⟱
| Source: |
| Type: |
IDE, Insulin-Degrading Enzyme
-Reduced IDE activity in AD contributes to Aβ accumulation.
-Enhancing IDE activity or expression may reduce Aβ burden.
|
Scientific Papers found: Click to Expand⟱
*neuroP↑, *Aβ↓, *p‑tau↓, *cognitive↑, *eff↑, *PKA↑, *CREB↑, *BACE/β-secretase↓, *ADAM10↑, *MAPK↑, *ERK↑, *PI3K↑, *Akt↑, *NRF2↑, *PPARγ↓, *IDE↑, *APP↓, *PP2A↑, *memory↑,
*memory↑, *cognitive↑, *neuroP↑, *Aβ↓, *mtDam↓, *Apoptosis↓, *PPARγ↑, *ROS↓, *SOD↑, *GSH↑, *NRF2↑, *MFN2↑, *DRP1/DNM1L↓, *FIS1↓, *Bcl-2↑, *BAX↓, *Cyt‑c↓, *cl‑Casp9↓, *cl‑Casp3↓, *IDE↑, *BACE/β-secretase↓, *Aβ42↓,
*antiOx↑, *Inflam↓, *AChE↓, *neuroP↑, *Mood↑, *cognitive↑, *memory↑, *Aβ↓, *BACE/β-secretase↓, *AEP↓, *IDE↑, *NEP↑, *LRP1↑, *PSD95↑, *STEP↓, *APP↓,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
Aβ42↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, GSH↑, 1, MFN2↑, 1, NRF2↑, 2, ROS↓, 1, SOD↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
DRP1/DNM1L↓, 1, FIS1↓, 1, mtDam↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
CREB↑, 1, PPARγ↓, 1, PPARγ↑, 1,
Cell Death(tgid=5) ⓘ
Akt↑, 1, Apoptosis↓, 1, BAX↓, 1, Bcl-2↑, 1, cl‑Casp3↓, 1, cl‑Casp9↓, 1, Cyt‑c↓, 1, MAPK↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ERK↑, 1, PI3K↑, 1,
Migration(tgid=13) ⓘ
APP↓, 2, LRP1↑, 1, PKA↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1, ADAM10↑, 1, PSD95↑, 1, p‑tau↓, 1,
Protein Aggregation(tgid=19) ⓘ
AEP↓, 1, Aβ↓, 3, BACE/β-secretase↓, 3, IDE↑, 3, NEP↑, 1, PP2A↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 1,
Functional Outcomes(tgid=23) ⓘ
cognitive↑, 3, memory↑, 3, Mood↑, 1, neuroP↑, 3, STEP↓, 1,
Total Targets: 43
Scientific Paper Hit Count for: IDE, Insulin-Degrading Enzyme
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1364 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page